Prenatal phthalates and early developmental screening

What the study says

Plain-English summary

Researchers combined pregnancy urine measurements from 10 ECHO cohorts and compared them with parent-completed developmental screening between ages one and three.

A few individual metabolites were associated with higher odds of delay in motor or problem-solving domains, while other estimates pointed in the opposite direction.

When the metabolites were assessed together as mixtures, most developmental domains did not show a statistically significant association. The study adds useful scale, but not a single, simple verdict.

Why it matters

Context

Large multi-cohort studies can reveal patterns that smaller studies miss. This one is equally valuable for showing uncertainty: selected signals appeared, but the overall mixture results were mostly null.

What it cannot prove

Limitations

This was observational research using a parent-reported screening tool, not a clinical diagnosis. Exposure measurements, multiple comparisons, and inconsistent directions make causal interpretation inappropriate.

Proportionate next steps

Practical actions

• Use practical exposure-reduction steps without treating developmental screening results as a product claim.
• Bring developmental concerns to a pediatric clinician rather than trying to identify one household cause.
• Expect future studies to refine which exposure windows and mixtures matter most.

Read it yourself

Original source

Prenatal phthalate exposure and neurodevelopmental delay in early childhood in the Environmental influences on Child Health Outcomes Program

DOI: 10.1016/j.envint.2026.110100